Close
Nordic 9Nordic 9

VP Venture Partners (investor - Venture Capital)

Switzerland vpventurepartners.com
See something wrong or missing? Let us know
Offices:Zurich
Average round investment:7.6M USD
Average number per year:1.0
Distribution: 2026 (1)2025 (1)2024 (1)2023 (1)2022 (1)
Portfolio companies: Austria DiamensAustria aTENSIONSwitzerland Hemotune AG See the entire list
Mostly invests in: Austria Austria (2) Health services (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to VP Venture Partners

Name Criteria
Switzerland Privilège Management
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland, Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Mey Capital Matrix
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Alchimia Investments
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Czech Republic TripleB
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Germany Nikolaus Bayer
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Switzerland Daniel Gutenberg
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Austria, Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom LongGame
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Circular Innovation Fund
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Erste Oetker Beteiligungs
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany Think Health
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland, Germany
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Top